The website of Pathology In Practice Magazine

Developments in cytocentrifugation

Regarded as the gold standard in cytocentrifugation, Cytospin is used in thousands of laboratories and a range of applications, and is cited extensively in published papers around the world.

Epredia was established in July 2019 from the acquisition by the PHC Group of the Anatomical Pathology division of Thermo Fisher Scientific. Powered by the trusted legacy brands such as Shandon, Microm and Menzel Gläser, Epredia has a wide breadth of solutions that have and will continue to transform the anatomical pathology market.

The extensive Epredia portfolio of high-quality instruments, consumables and microscope slides facilitates the efficient processing and accurate diagnosis of precious patient specimens. The legacy of the Epredia Cytospin is long – from the launch of the very first Shandon Cytospin in 1967 to the Epredia Cytospin 4 in the present day.

Learn more about Cytospin technology in the August issue of Pathology in Practice

www.epredia.com

 

Upcoming Events

Lab Innovations 2021

NEC, Birmingham
3-4 November 2021

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

Lab Innovations 2021

NEC, Birmingham
3-4 November 2021

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999 Fax: 01892 616177
www.step-communications.com
© 2021 Step Communications Ltd. Registered in England. Registration Number 3893025